.webp&w=828&q=75)
Island Pharmaceuticals has regained market attention after breaking a long-term downtrend, supported by Galidesivir developments and strong trading momentum. Recent updates across biodefence, manufacturing, and intellectual property have improved sentiment, although confirmation above key resistance remains important